Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs

Keyphrases

• Adverse Events 16%
• Asia 16%
• Body Composition 16%
• Clinical Development 16%
• Clinical Issues 16%
• Cost-effectiveness 16%
• Dose Adjustment 16%
• Enhanced Growth 16%
• Europe 16%
• GH Deficiency 33%
• Growth Velocity 16%
• Hormone Analogs 100%
• IGF-I Level 33%
• Injection Frequency 16%
• Long-acting GH 100%
• Long-acting Growth Hormone 100%
• Long-term Safety 16%
• Long-term Surveillance 16%
• Molecular Structure 16%
• Nave 16%
• Non-adherence 16%
• Non-inferiority 16%
• Patient Acceptance 16%
• Recombinant Human 33%
• Therapeutic Drug Monitoring 16%
• Therapeutic Efficacy 16%
• Tolerability 16%
• Treatment Outcome 16%
• United States 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 50%
• Combination Therapy 50%
• Growth Hormone Deficiency 100%
• Growth Hormone Derivative 100%
• Recombinant 100%
• Side Effect 100%
• Tolerability 50%